Which hedge funds own DNLI? DENALI THERAPEUTICS INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
8 of the hedge funds tracked by WhaleCreep disclosed a position in DNLI (DENALI THERAPEUTICS INC) in their Q2 2026 13F filings, worth $545.7m in total. The largest holder by portfolio weight is Casdin Capital at 2.6% of its book. 1 manager opened a new position this quarter: Tudor Investment. 1 exited: Polen Capital Management.
8tracked managers holding
1opened this quarter
1exited this quarter
Which hedge funds hold DNLI? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Casdin Capital | Q2 2026 | 2.6% | $52.6m | 2,045,000 | 11% | added |
| Baillie Gifford | Q2 2026 | 0.4% | $337.4m | 11,960,230 | -1% | reduced |
| Holocene Advisors | Q2 2026 | 0.2% | $100.4m | 3,905,225 | 22% | added |
| Woodline Partners | Q2 2026 | 0.0% | $9.4m | 364,082 | 0% | held |
| Millennium Management | Q2 2026 | 0.0% | $29.0m | 1,125,748 | -11% | reduced |
| Marshall Wace | Q2 2026 | 0.0% | $14.1m | 549,830 | -45% | reduced |
| Tudor Investment | Q2 2026 | 0.0% | $1.1m | 40,965 | – | new |
| Citadel Advisors | Q2 2026 | 0.0% | $1.7m | 66,971 | -63% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Polen Capital Management | 1.3% | $1.3m |
How has hedge fund ownership of DNLI changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 8 | $545.7m |
| Q1 2026 | 8 | $332.3m |
| Q4 2025 | 8 | $215.1m |
| Q3 2025 | 7 | $500.5m |
| Q2 2025 | 7 | $236.0m |
| Q1 2025 | 5 | $23.9m |
| Q4 2024 | 5 | $323.9m |
| Q3 2024 | 4 | $289.5m |
| Q2 2024 | 6 | $334.4m |
| Q1 2024 | 5 | $258.6m |
| Q4 2023 | 5 | $272.3m |
| Q3 2023 | 5 | $285.8m |
| Q2 2023 | 6 | $418.0m |
| Q1 2023 | 5 | $327.1m |
| Q4 2022 | 6 | $383.6m |
| Q3 2022 | 5 | $427.6m |
Counts every tracked manager that disclosed DNLI in that quarter's filing, including managers that have since stopped filing.